{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:16:35Z","timestamp":1790147795932,"version":"4.0.1"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>CXCL14 is a relatively new chemokine with unidentified receptor and undefined function. Recently, we found that CXCL14 is upregulated in arthritic joints in a mouse model of autoimmune arthritis, collagen-induced arthritis. To examine the role of CXCL14 in the development and pathogenesis of autoimmune arthritis, we have generated transgenic (Tg) mice that overexpress CXCL14 under control of phosphoglycerate kinase promoter. The results showed that CXCL14-Tg mice developed more severe arthritis compared with wild-type controls. The draining lymph nodes of CXCL14-Tg mice were significantly enlarged and contained an increased number of activated T cells, particularly the CD44+CD62Llow effector memory cells. In addition, T cells from CXCL14-Tg mice exhibited an enhanced proliferative response against collagen II and produced higher levels of IFN-\u03b3 but not IL-4 or IL-17. CXCL14-Tg mice also had elevated levels of IgG2a autoantibodies. These findings indicated that CXCL14 plays an important role in the autoimmune arthritis, which may have an implication in understanding the pathogenic mechanisms of rheumatoid arthritis in humans and, ultimately, therapeutic interference.<\/jats:p>","DOI":"10.4049\/jimmunol.0900525","type":"journal-article","created":{"date-parts":[[2010,3,9]],"date-time":"2010-03-09T00:19:17Z","timestamp":1268093957000},"page":"4455-4459","source":"Crossref","is-referenced-by-count":30,"title":["Overexpression of CXC Chemokine Ligand 14 Exacerbates Collagen-Induced Arthritis"],"prefix":"10.1093","volume":"184","author":[{"given":"Limo","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjie","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"He","sequence":"additional","affiliation":[{"name":"Department of Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Marinova","sequence":"additional","affiliation":[{"name":"Department of Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pumin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Molecular Physiology and Biophysics, Baylor College of Medicine , Houston, TX 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhua","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,4,15]]},"reference":[{"key":"2026012808074162300_r1","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/S0002-9440(10)65067-5","article-title":"In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue.","volume":"156","author":"Frederick","year":"2000","journal-title":"Am. J. Pathol."},{"key":"2026012808074162300_r2","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1006\/bbrc.1999.0257","article-title":"Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells.","volume":"255","author":"Hromas","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2026012808074162300_r3","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/intimm\/12.5.677","article-title":"B cell- and monocyte-activating chemokine (BMAC), a novel non-ELR alpha-chemokine.","volume":"12","author":"Sleeman","year":"2000","journal-title":"Int. Immunol."},{"key":"2026012808074162300_r4","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.bbrc.2006.07.070","article-title":"BRAK\/CXCL14 expression suppresses tumor growth in vivo in human oral carcinoma cells.","volume":"348","author":"Ozawa","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2026012808074162300_r5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/pros.20215","article-title":"Modulation of CXCL14 (BRAK) expression in prostate cancer.","volume":"64","author":"Schwarze","year":"2005","journal-title":"Prostate"},{"key":"2026012808074162300_r6","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.4049\/jimmunol.174.9.5490","article-title":"Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo.","volume":"174","author":"Shurin","year":"2005","journal-title":"J. Immunol."},{"key":"2026012808074162300_r7","doi-asserted-by":"crossref","first-page":"8262","DOI":"10.1158\/0008-5472.CAN-04-2056","article-title":"BRAK\/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells.","volume":"64","author":"Shellenberger","year":"2004","journal-title":"Cancer Res."},{"key":"2026012808074162300_r8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.immuni.2005.08.012","article-title":"Cutaneous CXCL14 targets blood precursors to epidermal niches for Langerhans cell differentiation.","volume":"23","author":"Schaerli","year":"2005","journal-title":"Immunity"},{"key":"2026012808074162300_r9","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1080\/08916930802095210","article-title":"Gene expression profiles at different stages of collagen-induced arthritis.","volume":"41","author":"Booth","year":"2008","journal-title":"Autoimmunity"},{"key":"2026012808074162300_r10","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1002\/1521-4141(200006)30:6<1568::AID-IMMU1568>3.0.CO;2-R","article-title":"Collagen-induced arthritis in C57BL\/6 (H-2b) mice: new insights into an important disease model of rheumatoid arthritis.","volume":"30","author":"Campbell","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"2026012808074162300_r11","doi-asserted-by":"crossref","first-page":"7087","DOI":"10.4049\/jimmunol.179.10.7087","article-title":"Overexpression of Bcl(XL) in B cells promotes Th1 response and exacerbates collagen-induced arthritis.","volume":"179","author":"Zheng","year":"2007","journal-title":"J. Immunol."},{"key":"2026012808074162300_r12","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/1529-0131(200106)44:6<1438::AID-ART239>3.0.CO;2-Q","article-title":"Germinal center reaction in the joints of mice with collagen-induced arthritis: an animal model of lymphocyte activation and differentiation in arthritis joints.","volume":"44","author":"Han","year":"2001","journal-title":"Arthritis Rheum."},{"key":"2026012808074162300_r13","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/eji.1830260716","article-title":"Relationship between Th1\/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis.","volume":"26","author":"Mauri","year":"1996","journal-title":"Eur. J. Immunol."},{"key":"2026012808074162300_r14","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/eji.1830270623","article-title":"Conversion in vivo from an early dominant Th0\/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis.","volume":"27","author":"Doncarli","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"2026012808074162300_r15","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/art.1780400209","article-title":"Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction.","volume":"40","author":"Joosten","year":"1997","journal-title":"Arthritis Rheum."},{"key":"2026012808074162300_r16","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/BOR.0b013e32805e87f1","article-title":"Update on cytokines in rheumatoid arthritis.","volume":"19","author":"Brennan","year":"2007","journal-title":"Curr. Opin. Rheumatol."},{"key":"2026012808074162300_r17","doi-asserted-by":"crossref","first-page":"iii29","DOI":"10.1136\/ard.2006.058529","article-title":"Potential new targets in arthritis therapy: interleukin (IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritis.","volume":"65","author":"Koenders","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"2026012808074162300_r18","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/art.1780270907","article-title":"Type II collagen-induced arthritis in mice. II. Passive transfer and suppression by intravenous injection of anti-type II collagen antibody or free native type II collagen.","volume":"27","author":"Wooley","year":"1984","journal-title":"Arthritis Rheum."},{"key":"2026012808074162300_r19","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.4049\/jimmunol.148.7.2103","article-title":"Induction of arthritis with monoclonal antibodies to collagen.","volume":"148","author":"Terato","year":"1992","journal-title":"J. Immunol."},{"key":"2026012808074162300_r20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev.iy.08.040190.001511","article-title":"Lymphokine control of in vivo immunoglobulin isotype selection.","volume":"8","author":"Finkelman","year":"1990","journal-title":"Annu. Rev. Immunol."},{"key":"2026012808074162300_r21","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1128\/MCB.01648-06","article-title":"Murine CXCL14 is dispensable for dendritic cell function and localization within peripheral tissues.","volume":"27","author":"Meuter","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"2026012808074162300_r22","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1084\/jem.194.6.855","article-title":"Monocyte selectivity and tissue localization suggests a role for breast and kidney-expressed chemokine (BRAK) in macrophage development.","volume":"194","author":"Kurth","year":"2001","journal-title":"J. Exp. Med."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/184\/8\/4455\/62711670\/ji_0900525.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/184\/8\/4455\/62711670\/ji_0900525.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T13:07:57Z","timestamp":1769605677000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/184\/8\/4455\/8013281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":22,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2010,4,15]]},"published-print":{"date-parts":[[2010,4,15]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.0900525","relation":{},"ISSN":["1550-6606","0022-1767"],"issn-type":[{"value":"1550-6606","type":"electronic"},{"value":"0022-1767","type":"print"}],"subject":[],"published-other":{"date-parts":[[2010,4]]},"published":{"date-parts":[[2010,4]]}}}